NCT03827239

Brief Summary

Individuals with pre-diabetes or diabetes would benefit from low impact methods that would improve their insulin sensitivity and aid in maintaining glucose homeostasis. Physical activity helps the body decrease its insulin resistance and burn excess sugar. Many diabetics also suffer from obesity and specific forms or durations of physical exercise may not be viable options for these individuals. Determining whether short bursts of moderate exercise improve blood glucose levels in healthy humans may identify a further method for diabetics to improve their glucose homeostasis. The aim of this study is to determine the most effective moderate exercise that can be completed in 3 minutes and its effectiveness on improving glucose handling, in response to a single day of standardized high-fat and high-carbohydrate feeding in comparison to periods of prolonged sitting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 17, 2019

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 22, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 1, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

January 29, 2021

Status Verified

January 1, 2019

Enrollment Period

10 months

First QC Date

January 22, 2019

Last Update Submit

January 26, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Insulin levels

    The change in blood insulin levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).

    Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days

  • Change in concentration of C-peptide

    The change in blood C-peptide levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).

    Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days

  • Changes in blood glucose levels

    Blood glucose levels will be determined at pre-prandial baseline and over the following 3-hour testing period using hand-held blood glucose meters.

    Baseline and every 30-60 minutes over 3 hours (6 timepoints per test day)

  • Change in metabolomic response to a test meal

    Targeted metabolomics analysis of approximately 139 metabolites in blood serum by LC-MS/MS to generate a metabolomic profile in response to a high-fat and high-carbohydrate test meal. Metabolites to be determined are categorized as biogenic amines, amino acids, histidines, carboxylic acids, acylcarnitines, glycerophospholipids and organic acids.

    Pre-prandial and 3-hours post test meal through study completion

Secondary Outcomes (6)

  • Immediate effects of short-term sedentary behaviour on cognitive function

    3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  • Immediate effects of short-term sedentary behaviour on cognitive function

    3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  • Immediate effects of short-term sedentary behaviour on cognitive function

    3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  • Immediate effects of short-term sedentary behaviour on cognitive function

    3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  • Immediate effects of short-term sedentary behaviour on cognitive function

    3 hours post-activity (sedentary behaviour or exercise) on test days through study completion

  • +1 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

No intervention. Study participants will be seated during the entire sedentary 3-hour time period and wheeled to phlebotomy (and exercise) stations when required. During the sedentary period, participants will eat the food according to the study protocol and be seated at desks and allowed to read and use computers.

Intervention

EXPERIMENTAL

Will disrupt their sedentary time with 3 minute exercise sessions every 30 minutes

Other: Activity/Moderate Exercise

Interventions

3-hour sedentary period with 3 minute activity breaks of moderate exercise every 30 minutes

Intervention

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy
  • BMI between 18-30 kg/m²
  • non-smoker

You may not qualify if:

  • pregnant
  • diabetes
  • kidney disease
  • liver disease
  • cardiovascular disease
  • cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Prince Edward Island

Charlottetown, Prince Edward Island, C1A 4P3, Canada

Location

MeSH Terms

Conditions

Sedentary BehaviorInsulin Resistance

Interventions

Exercise

Condition Hierarchy (Ancestors)

BehaviorHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Magdalena Mahlstedt, PhD

    University of Prince Edward Island

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2019

First Posted

February 1, 2019

Study Start

January 17, 2019

Primary Completion

October 31, 2019

Study Completion

December 31, 2019

Last Updated

January 29, 2021

Record last verified: 2019-01

Locations